Voluntary deposit by author of pre-print allowed on Institutions open scholarly website and pre-print servers
Voluntary deposit by author of authors post-print allowed on institutions open scholarly website including Institutional Repository
Deposit due to Funding Body, Institutional and Governmental mandate only allowed where separate agreement between repository and publisher exists
Set statement to accompany deposit
Published source must be acknowledged
Must link to journal home page or articles' DOI
Publisher's version/PDF cannot be used
Articles in some journals can be made Open Access on payment of additional charge
NIH Authors articles will be submitted to PMC after 12 months
Authors who are required to deposit in subject repositories may also use Sponsorship Option
All documents in ORBi are protected by a user license.
[en] PURPOSE: To report the first case of choroidal schwannoma in a patient affected by PTEN hamartoma tumor syndrome (PHTS) and investigate the molecular involvement of the phosphatase and tensin homolog (PTEN) and neurofibromin 2 (NF2) genes in this rare intraocular tumor. DESIGN: Observational case report. PARTICIPANT: A 10-year-old girl diagnosed with PHTS. METHODS: The enucleated specimen underwent histologic, immunohistochemical, and transmission electronic microscopy. The expression of PTEN and NF2 and their protein products were evaluated by reverse transcription-polymerase chain reaction and immunohistochemistry. Somatic mutations of PTEN and NF2, as well as allelic loss, were investigated by direct sequencing of DNA extracted from the tumor. PTEN epigenetic silencing was investigated by pyrosequencing. MAIN OUTCOME MEASURES: Histopathologic and molecular characterization of a choroidal pigmented schwannoma. RESULTS: Histopathologic, immunohistochemical, and electron microscopic analysis demonstrated features consistent with a pigmented cellular schwannoma of the choroid. We found no loss of heterozygosity at the genomic level for the PTEN germline mutation and no promoter hypermethylation or other somatic intragenic mutations. However, we observed an approximate 40% reduction of PTEN expression at both the mRNA and the protein level, indicating that the tumor was nonetheless functionally deficient for PTEN. Although DNA sequencing of NF2 failed to identify any pathologic variants, its expression was abolished within the tumor. CONCLUSIONS: We report the first description of a pigmented choroidal schwannoma in the context of a PHTS. This rare tumor showed a unique combination of reduction of PTEN and absence of NF2 expression.
Disciplines :
Ophthalmology
Author, co-author :
Venturini, Giulia
Moulin, Alexandre P.
DEPREZ, Manuel ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique
Uffer, Sylvie
Bottani, Armand
Zografos, Leonidas
Rivolta, Carlo
Language :
English
Title :
Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome.
Publication date :
2012
Journal title :
Ophthalmology
ISSN :
0161-6420
eISSN :
1549-4713
Publisher :
Elsevier, New York, United States - New York
Volume :
119
Issue :
4
Pages :
857-64
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
C. Mawrin, E. Kirches, C. Boltze, K. Dietzmann PTEN is not altered in sporadic vestibular schwannomas Histopathology 40 2002 526 530 (Pubitemid 34621810)
G.A. Rouleau, P. Merel, M. Lutchman Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 Nature 363 1993 515 521 (Pubitemid 23186636)
J.A. Trofatter, M.M. MacCollin, J.L. Rutter A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor Cell 72 1993 791 800 (Pubitemid 23093886)
I. Stamenkovic, Q. Yu Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival Curr Protein Pept Sci 11 2010 471 484
Z. Ahmad, C.M. Brown, A.K. Patel Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis Otol Neurotol 31 2010 460 466
J.A. Hobert, C. Eng PTEN hamartoma tumor syndrome: an overview Genet Med 11 2009 687 694
T.M. Starink, J.P. van der Veen, F. Arwert The Cowden syndrome: a clinical and genetic study in 21 patients Clin Genet 29 1986 222 233 (Pubitemid 16136974)
N. Vantomme, F. Van Calenbergh, J. Goffin Lhermitte-Duclos disease is a clinical manifestation of Cowden's syndrome Surg Neurol 56 2001 201 205
G.B. Wells, T.M. Lasner, D.M. Yousem, E.L. Zager Lhermitte-Duclos disease and Cowden's syndrome in an adolescent patient: case report J Neurosurg 81 1994 133 136 (Pubitemid 24195520)
J.J. Gicquel, P. Vabres, D. Bonneau Retinal angioma in a patient with Cowden disease Am J Ophthalmol 135 2003 400 402 (Pubitemid 36279536)
M. Dvir, S. Beer, M. Aladjem Heredofamilial syndrome of mesodermal hamartomas, macrocephaly, and pseudopapilledema Pediatrics 81 1988 287 290 (Pubitemid 18060611)
J.P. Burke, R. Bowell, N. O'Doherty Proteus syndrome: ocular complications J Pediatr Ophthalmol Strabismus 25 1988 99 102 (Pubitemid 18077737)
E.A. Bouzas, D. Krasnewich, M. Koutroumanidis Ophthalmologic examination in the diagnosis of Proteus syndrome Ophthalmology 100 1993 334 338 (Pubitemid 23088531)
R.M. Sheard, F.M. Pope, M.P. Snead A novel ophthalmic presentation of the Proteus syndrome Ophthalmology 109 2002 1192 1195 (Pubitemid 34546933)
I. De Becker, D.J. Gajda, E. Gilbert-Barness, M.M. Cohen Jr Ocular manifestations in Proteus syndrome Am J Med Genet 92 2000 350 352 (Pubitemid 30341479)
J. Lopiccolo, M.S. Ballas, P.A. Dennis PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development Crit Rev Oncol Hematol 63 2007 203 214 (Pubitemid 47126868)
J.V. Schaffer, H. Kamino, A. Witkiewicz Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome Arch Dermatol 142 2006 625 632 (Pubitemid 43727554)
O. Gimm, T. Attie-Bitach, J.A. Lees Expression of the PTEN tumour suppressor protein during human development Hum Mol Genet 9 2000 1633 1639 (Pubitemid 30427000)
L.B. Jacoby, M. MacCollin, D.N. Louis Exon scanning for mutation of the NF2 gene in schwannomas Hum Mol Genet 3 1994 413 419 (Pubitemid 24083900)
A. Mirmohammadsadegh, A. Marini, S. Nambiar Epigenetic silencing of the PTEN gene in melanoma Cancer Res 66 2006 6546 6552 (Pubitemid 44085609)
B. Jenny, I. Radovanovic, C.A. Haenggeli Association of multiple vertebral hemangiomas and severe paraparesis in a patient with a PTEN hamartoma tumor syndrome: case report J Neurosurg 107 Suppl 2007 307 313
Y. Kubo, Y. Urano, Y. Hida A novel PTEN mutation in a Japanese patient with Cowden disease Br J Dermatol 142 2000 1100 1105 (Pubitemid 30418294)
E. Saavedra, A.D. Singh, J.E. Sears, N.B. Ratliff Plexiform pigmented schwannoma of the uvea Surv Ophthalmol 51 2006 162 168 (Pubitemid 43269941)
J.T. Fan, R.J. Campbell, D.M. Robertson A survey of intraocular schwannoma with a case report Can J Ophthalmol 30 1995 37 41
T. Matsuo, K. Notohara Choroidal schwannoma: immunohistochemical and electron-microscopic study Ophthalmologica 214 2000 156 160 (Pubitemid 30179215)
J.A. Shields, R.L. Font, R.C. Eagle Jr Melanotic schwannoma of the choroid: immunohistochemistry and electron microscopic observations Ophthalmology 101 1994 843 849 (Pubitemid 24177674)
R.A. Erlandson, J.M. Woodruff Peripheral nerve sheath tumors: an electron microscopic study of 43 cases Cancer 49 1982 273 287 (Pubitemid 12211842)
O. Kurtkaya-Yapicier, B. Scheithauer, J.M. Woodruff The pathobiologic spectrum of schwannomas Histol Histopathol 18 2003 925 934 (Pubitemid 36773236)
J. Escalona-Zapata, M.D. Diez Nau The nature of macrophages (foam cells) in neurinomas: tissue culture study Acta Neuropathol 44 1978 71 75 (Pubitemid 9033315)
R.L. Font, L.D. Truong Melanotic schwannoma of soft tissues: electron-microscopic observations and review of literature Am J Surg Pathol 8 1984 129 138 (Pubitemid 14196545)
A.F. Hottinger, Y. Khakoo Update on the management of familial central nervous system tumor syndromes Curr Neurol Neurosci Rep 7 2007 200 207 (Pubitemid 46831513)
J.W. Harbour, S.L. Lai, J. Whang-Peng Abnormalities in structure and expression of the human retinoblastoma gene in SCLC Science 241 1988 353 357
B. Kwabi-Addo, D. Giri, K. Schmidt Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression Proc Natl Acad Sci U S A 98 2001 11563 11568 (Pubitemid 32928768)
N. Sato, H. Tsunoda, M. Nishida Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary Cancer Res 60 2000 7052 7056 (Pubitemid 32059184)
K. Kurose, X.P. Zhou, T. Araki, C. Eng Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas Genes Chromosomes Cancer 29 2000 166 172
A. Goel, C.N. Arnold, D. Niedzwiecki Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers Cancer Res 64 2004 3014 3021 (Pubitemid 38581399)
J.M. Garcia, J. Silva, C. Pena Promoter methylation of the PTEN gene is a common molecular change in breast cancer Genes Chromosomes Cancer 41 2004 117 124 (Pubitemid 39096737)
C. Eng PTEN: one gene, many syndromes Hum Mutat 22 2003 183 198 (Pubitemid 37071635)
Z. Lian, A. Di Cristofano Class reunion: PTEN joins the nuclear crew Oncogene 24 2005 7394 7400 (Pubitemid 41637979)
A. Carracedo, A. Alimonti, P.P. Pandolfi PTEN level in tumor suppression: how much is too little? Cancer Res 71 2011 629 633
A. Alimonti, A. Carracedo, J.G. Clohessy Subtle variations in Pten dose determine cancer susceptibility Nat Genet 42 2010 454 458
L.C. Trotman, M. Niki, Z.A. Dotan Pten dose dictates cancer progression in the prostate [report online] PLoS Biol 1 2003 E59 http://www.plosbiology.org/ article/info%3Adoi%2F10.1371%2Fjournal.pbio.0000059 Accessed September 26, 2011
J.A. Cioffi, W.Y. Yue, S. Mendolia-Loffredo MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival Otol Neurotol 31 2010 1455 1462
A.A. Sandberg, J.F. Stone Benign peripheral nerve sheath tumors: neurofibromas, schwannomas, and perineuriomas The Genetics and Molecular Biology of Neural Tumors 2008 Humana Press Totowa, NJ 6 19
M.E. Bickler-Bluth, P.L. Custer, M.E. Smith Neurilemoma as a presenting feature of neurofibromatosis Arch Ophthalmol 106 1988 665 667
S.F. Freedman, V.M. Elner, I. Donev Intraocular neurilemmoma arising from the posterior ciliary nerve in neurofibromatosis: pathologic findings Ophthalmology 95 1988 1559 1564
S. Vannas, C. Raitta, A. Tarkkanen Neurilemmoma of the choroid in Recklinghausen's disease Acta Ophthalmol Suppl 123 1974 126 133
J.C. Maroon, J.S. Kennerdell, A. Abla The diagnosis and treatment of orbital tumors Clin Neurosurg 34 1988 485 498
